Changed Risks for CONMED CORP (CNMD)

Here are risks that changed year over year. risks from the recent filings of CONMED CORP. Our algorithms work hard to highlight risks unique to this company.

The conditional conversion features of our 2625% Convertible Notes due 2024 (the “Convertible Notes”), if triggered, may adversely affect our financial condition

Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly

We distribute some products for third-party companies, and cannot ensure that our rights to distribute such third-party products will continue indefinitely

(iv) Other Risks Related to Our Business

(ii) Risks Related to Our Indebtedness

The terms of our indebtedness outstanding from time to time, including our senior credit agreement, may restrict our current and future operations, particularly our ability to respond to changes or to take certain actions

Despite our current level of indebtedness, we and our subsidiaries may still be able to incur substantially more debt This could further exacerbate the risks to our financial condition described above

The convertible note hedge and warrant transactions that we entered into in connection with the offering of the Convertible Notes may affect the value of the Convertible Notes and our common stock

The terms of any future preferred equity or debt financing may give holders of any preferred securities or debt securities rights that are senior to rights of our common shareholders or impose more stringent operating restrictions on our company

We can be sued for product liability claims and our insurance coverage may be insufficient to cover the nature and amount of any product liability claims

pro forma

We are subject to counterparty risk with respect to the convertible note hedge transactions

If we lose our patents or they are held to be invalid, or if our products or services infringe on third party patents, we could become subject to liability and our competitive position could be harmed

Our significant international operations subject us to foreign currency fluctuations and other risks associated with operating in countries outside the United States

We may not be able to generate sufficient cash to service our indebtedness, and, our leverage and debt service requirements may require us to adopt alternative business strategies

(i) Risks Related to Our Business and the Medical Device Industry

Anti-takeover provisions in our organizational documents and New York law could delay or prevent a change in control

(iii) Risks Related to Our Acquisition Strategy